EUVIMEDOpdag EUVIMED
Open access · CC BY-NC-ND 4.0

Single cell G‐protein coupled receptor profiling of activated kidney fibroblasts expressing transcription factor 21

Harmandeep Kaur, Veera Ganesh Yerra, Sri Nagarjun Batchu, Duc Tin Tran, M D Golam Kabir, Youan Liu, Suzanne L Advani, Phelopater Sedrak, Laurette Geldenhuys, Karthik K Tennankore, Penelope Poyah, Ferhan S Siddiqi and 1 more

British Journal of Pharmacology · 2023

DOI: 10.1111/bph.16101 ↗

At a glance

Journal article in British Journal of Pharmacology, 2023. Written by Harmandeep Kaur and 12 co-authors. Institution: Keenan Research Centre for Biomedical Science and Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Ontario, Canada. Major MEDLINE topics: Diabetes Mellitus, Experimental, Kidney Diseases, Renal Insufficiency, Chronic, Ureteral Obstruction. Cited 14 times so far (Crossref); 74 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: NIH HHS, Banting and Best Diabetes Centre, University of Toronto, Canadian Institutes of Health Research.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background and Purpose Activated fibroblasts deposit fibrotic matrix in chronic kidney disease (CKD) and G‐protein coupled receptors (GPCRs) are the most druggable therapeutic targets. Here, we set out to establish a transcriptional profile that identifies activated kidney fibroblasts and the GPCRs that they express. Experimental Approach RNA sequencing and single cell qRT‐PCR were performed on mouse kidneys after unilateral ureteral obstruction (UUO). Candidate expression was evaluated in mice with UUO or diabetes or injected with adriamycin or folic acid. Intervention studies were conducted in mice with diabetes or UUO. Correlative histology was performed in human kidney tissue. Key Results Transcription factor 21 ( Tcf21 )+ cells that expressed 2 or 3 of Postn , Acta2 and Pdgfra were highly enriched for fibrogenic genes and were defined as activated kidney fibroblasts. Tcf21 + α‐smooth muscle actin (α‐SMA)+ interstitial cells accumulated in kidneys of mice with UUO or diabetes or injected with adriamycin or folic acid, whereas renin‐angiotensin system blockade attenuated increases in Tcf21 in diabetic mice. Fifty‐six GPCRs were up‐regulated in single Tcf21 + kidney fibroblasts, the most up‐regulated being Adgra2 and S1pr3 . Adenosine receptors, Adora2a/2b , were up‐regulated in Tcf21 + fibroblasts and the adenosine receptor antagonist, caffeine decreased Tcf21 upregulation and kidney fibrosis in UUO mice. TCF21 , ADGRA2 , S1PR3 and ADORA2A /2B were each detectable in α‐SMA+ interstitial cells in human kidney samples. Conclusion and Implications Tcf21 is a marker of kidney fibroblasts that are enriched for fibrogenic genes in CKD. Further analysis of the GPCRs expressed by these cells may identify new targets for treating CKD. LINKED ARTICLES This article is part of a themed issue on Translational Advances in Fibrosis as a Therapeutic Target. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v180.22/issuetoc

Subjects

MeSH terms (MEDLINE)

Diabetes Mellitus, ExperimentalKidney DiseasesRenal Insufficiency, ChronicUreteral ObstructionAnimalsHumansMiceBasic Helix-Loop-Helix ProteinsDoxorubicinFibroblastsFibrosisFolic AcidKidneyMice, Inbred C57BLReceptors, G-Protein-CoupledTranscription Factors

Author keywords

GPCRTcf21adenosine receptorfibroblastfibrosiskidney

Substances

Basic Helix-Loop-Helix ProteinsDoxorubicinFolic AcidReceptors, G-Protein-CoupledTranscription FactorsTCF21 protein, humanTcf21 protein, mouse

Authors and institutions

  • Keenan Research Centre for Biomedical Science and Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Ontario, Canada.
  • Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
  • Department of Pathology, Dalhousie University, Halifax, Nova Scotia, Canada.
  • Department of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada.

Funding

  • NIH HHS
  • Banting and Best Diabetes Centre, University of Toronto
  • Canadian Institutes of Health Research
  • Diabetes Canada
  • Heart and Stroke Foundation of Canada
  • Kidney Foundation of Canada

Cite

APA

Kaur, H., Yerra, V. G., Batchu, S. N., Tran, D. T., Kabir, M. D. G., Liu, Y., Advani, S. L., Sedrak, P., Geldenhuys, L., Tennankore, K. K., Poyah, P., Siddiqi, F. S., & Advani, A. (2023). Single cell G‐protein coupled receptor profiling of activated kidney fibroblasts expressing transcription factor 21. British Journal of Pharmacology. https://doi.org/10.1111/bph.16101

Vancouver

Kaur H, Yerra VG, Batchu SN, Tran DT, Kabir MDG, Liu Y, et al. Single cell G‐protein coupled receptor profiling of activated kidney fibroblasts expressing transcription factor 21. British Journal of Pharmacology. 2023. doi:10.1111/bph.16101

BibTeX
@article{Kaur2023,
  author = {Kaur, Harmandeep and Yerra, Veera Ganesh and Batchu, Sri Nagarjun and Tran, Duc Tin and Kabir, M D Golam and Liu, Youan and Advani, Suzanne L and Sedrak, Phelopater and Geldenhuys, Laurette and Tennankore, Karthik K and Poyah, Penelope and Siddiqi, Ferhan S and Advani, Andrew},
  title = {Single cell G‐protein coupled receptor profiling of activated kidney fibroblasts expressing transcription factor 21},
  journal = {British Journal of Pharmacology},
  year = {2023},
  doi = {10.1111/bph.16101}
}
Start for free →